U.S. pharma huge copyright scrapped two experimental weight loss tablets very last calendar year—a at the time-each day pill, lotiglipron, resulting from elevated liver enzymes and a two times-every day pill, danuglipron, as a result of powerful Unintended effects—but CEO Albert Bour